Pursue Wealth Partners LLC Increases Holdings in Axon Enterprise, Inc $AXON

by · The Markets Daily

Pursue Wealth Partners LLC increased its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 27.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,910 shares of the biotechnology company’s stock after purchasing an additional 842 shares during the quarter. Axon Enterprise makes up about 1.2% of Pursue Wealth Partners LLC’s portfolio, making the stock its 29th biggest position. Pursue Wealth Partners LLC’s holdings in Axon Enterprise were worth $2,192,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of AXON. Vanguard Group Inc. increased its stake in shares of Axon Enterprise by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 9,367,224 shares of the biotechnology company’s stock valued at $5,319,928,000 after buying an additional 53,060 shares during the period. Geode Capital Management LLC grew its holdings in Axon Enterprise by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 2,226,159 shares of the biotechnology company’s stock worth $1,265,657,000 after acquiring an additional 35,544 shares in the last quarter. Sands Capital Management LLC increased its position in Axon Enterprise by 11.6% during the 4th quarter. Sands Capital Management LLC now owns 1,609,436 shares of the biotechnology company’s stock valued at $914,047,000 after purchasing an additional 167,095 shares during the period. Wellington Management Group LLP increased its position in Axon Enterprise by 326.9% during the 4th quarter. Wellington Management Group LLP now owns 1,539,738 shares of the biotechnology company’s stock valued at $874,463,000 after purchasing an additional 1,179,038 shares during the period. Finally, Edgewood Management LLC bought a new stake in shares of Axon Enterprise in the 4th quarter valued at about $846,516,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts recently commented on AXON shares. Citizens Jmp reissued a “market outperform” rating and issued a $700.00 price objective on shares of Axon Enterprise in a research note on Thursday, June 25th. Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Friday, July 10th. Royal Bank Of Canada reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. UBS Group upped their price objective on Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Finally, TD Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, July 22nd. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $730.92.

View Our Latest Analysis on Axon Enterprise

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $604.32 on Tuesday. The business’s 50 day moving average price is $528.72 and its 200 day moving average price is $473.44. The firm has a market cap of $49.09 billion, a P/E ratio of 250.76, a P/E/G ratio of 9.95 and a beta of 1.39. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $794.29. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. During the same quarter in the prior year, the company earned $2.12 EPS. Axon Enterprise’s quarterly revenue was up 35.3% on a year-over-year basis. On average, sell-side analysts expect that Axon Enterprise, Inc will post 2.04 earnings per share for the current year.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CRO Cameron Brooks sold 1,242 shares of the company’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $621,000.00. Following the sale, the executive directly owned 49,710 shares of the company’s stock, valued at approximately $24,855,000. This represents a 2.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 9,930 shares of the stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $548.77, for a total value of $5,449,286.10. Following the sale, the chief executive officer directly owned 3,031,067 shares in the company, valued at $1,663,358,637.59. This represents a 0.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 68,989 shares of company stock valued at $36,016,932. 4.20% of the stock is owned by corporate insiders.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Featured Articles

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).